⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BBIO News
BridgeBio Pharma, Inc. Common Stock
The Speak Foundation Announces 2026 LGMD Scientific Summit
prnewswire.com
BBIO
SRPT
ASMB
EDIT
Form 8-K
sec.gov
BBIO
BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
globenewswire.com
BBIO
Rinascera Therapeutics Launches with Clinical-Stage Pipeline to Transform the Treatment of Genetic Skin Diseases
globenewswire.com
BBIO
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO
Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Protective Effects in ATTR-CM
globenewswire.com
BBIO
BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches
globenewswire.com
BBIO
KKR
BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children Living with Achondroplasia
globenewswire.com
BBIO
Form 8-K
sec.gov
BBIO